Sign in

CIK 0001982708 · Non-accelerated filer<br>Emerging growth company

Anbio Biotechnology

Sign in to watch
Ticker
NNNN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
other
Phone
4916096247281
Business address
FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, Germany, 60308
  1. F-3ASR Offering Registration Statement
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 20-F/A Report Annual and Transition Report of Foreign Private Issuers
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 20-F Report Annual and Transition Report of Foreign Private Issuers
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. 6-K Event Report of Foreign Issuer
  17. 20-F Report Annual and Transition Report of Foreign Private Issuers
  18. 6-K Event Report of Foreign Issuer
  19. 424B4 Offering Prospectus
  20. EFFECT Other Notice of Effectiveness

Page 1 of 3 · 43 filings